SCHEMBL6835892

SCHEMBL6835892

Cn1c(=O)c2[nH]c(-c3ccccc3)nc2n(CS(=O)(=O)O)c1=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 10/20 0.65
ADORA2A P29274 7/20 0.65
ADORA1 P30542 6/20 0.65
KDM4E B2RXH2 5/20 0.65
HSD17B10 Q99714 5/20 0.65
ADORA3 P0DMS8 5/20 0.65
CYP1A2 P05177 3/20 0.65
BLM P54132 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65
ALDH1A1 P00352 4/20 0.60
CYP3A4 P08684 2/20 0.60
CYP2C19 P33261 2/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
CYP2C9 P11712 1/20 0.60
HPGD P15428 3/20 0.58
TSHR P16473 2/20 0.58
MAPK1 P28482 1/20 0.58
THPO P40225 1/20 0.58
PMP22 Q01453 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9840392 0.84 ADORA2B (0.81) ADORA2BADORA2AADORA1KDM4EHSD17B10
SCHEMBL10616171 0.83 ADORA2B (0.68) ADORA2BADORA2AADORA1KDM4EHSD17B10
SCHEMBL9765918 0.83 ADORA2B (0.85) ADORA2BADORA2AADORA1KDM4EHSD17B10
8-Phenyl Theophylline SCHEMBL516432 0.80 ADORA2A (1.00) ADORA2BADORA2AADORA1KDM4EHSD17B10
SCHEMBL9765879 0.76 ADORA2B (0.85) ADORA2BADORA2AADORA1KDM4EHSD17B10
SCHEMBL661108 0.75 ADORA2B (1.00) ADORA2BADORA2AADORA1KDM4EHSD17B10
SCHEMBL1321894 0.74 ADORA2B (1.00) ADORA2BADORA2AADORA1KDM4EHSD17B10
SCHEMBL1320226 0.73 ADORA2B (1.00) ADORA2BADORA2AADORA1KDM4EHSD17B10
SCHEMBL9765909 0.73 ADORA2B (1.00) ADORA2BADORA2AADORA1KDM4EHSD17B10
SCHEMBL27140351 0.72 ADORA2B (0.97) ADORA2BADORA2AADORA1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058170-A9 METHODS FOR TREATING MALARIA BY MODULATION OF G PROTEIN FUNCTION UNIV NORTHWESTERN (US) 2004-08-19 WO disclosed
WO-2004058170-A2 METHODS FOR TREATING MALARIA BY MODULATION OF G PROTEIN FUNCTION NORTHWESTERN UNIVERSITY (US) 2004-07-15 WO disclosed
US-5658889-A ADMINISTERING 5-AMINO-4-IMIDAZLECARBOXAMIDE RIBOSIDE WHICH BINDS ADENOSINE MONOPHOSPHATE SITE OF FRUCTOSE-1,6-DIPHOSPHATASE GENSIA PHARMACEUTICALS, INC. (US) 1997-08-19 US disclosed
EP-0427799-B1 METHOD AND COMPOUNDS FOR AICA RIBOSIDE DELIVERY AND FOR LOWERING BLOOD GLUCOSE GENSIA PHARMA (US) 1994-11-30 EP disclosed
EP-0427799-A4 METHOD AND COMPOUNDS FOR AICA RIBOSIDE DELIVERY AND FOR LOWERING BLOOD GLUCOSE 1991-07-24 EP disclosed
EP-0427799-A1 METHOD AND COMPOUNDS FOR AICA RIBOSIDE DELIVERY AND FOR LOWERING BLOOD GLUCOSE. GENSIA PHARMA (US) 1991-05-22 EP disclosed
WO-1990009163-A2 METHOD AND COMPOUNDS FOR AICA RIBOSIDE DELIVERY AND FOR LOWERING BLOOD GLUCOSE GENSIA PHARMACEUTICALS, INC. (US) 1990-08-23 WO disclosed